Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$468M |
| 2 |
Johnson & Johnson
JNJ
|
+$440M |
| 3 |
IBM
IBM
|
+$355M |
| 4 |
Booking.com
BKNG
|
+$332M |
| 5 |
RAI
Reynolds American Inc
RAI
|
+$331M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LLTC
Linear Technology Corp
LLTC
|
+$482M |
| 2 |
Walt Disney
DIS
|
+$247M |
| 3 |
Visa
V
|
+$219M |
| 4 |
Deere & Co
DE
|
+$200M |
| 5 |
Johnson Controls International
JCI
|
+$179M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.02% |
| 2 | Technology | 13.31% |
| 3 | Financials | 12.25% |
| 4 | Industrials | 9.65% |
| 5 | Consumer Staples | 9.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1876
G. Willi-Food International
WILC
$396M
| $3.74M | 0.01% |
616,600
+9,500
| +2% | +$60.6K |
|
|
EGN
1877
DELISTED
Energen
EGN
| $3.73M | 0.01% |
68,500
-107,200
| -61% | -$5.8M |
|
|
GLBL
1878
DELISTED
TerraForm Global, Inc. Class A Common Stock
GLBL
| $3.73M | 0.01% |
+776,809
| New | +$3.51M |
|
|
NSM
1879
DELISTED
Nationstar Mortgage Holdings
NSM
| $3.72M | 0.01% |
236,200
+35,000
| +17% | +$619K |
|
1880
Vicor
VICR
$10.4B
| $3.72M | 0.01% |
231,200
-24,000
| -9% | -$370K |
|
1881
Cheniere Energy
LNG
$55B
| $3.72M | 0.01% |
78,700
-127,200
| -62% | -$5.87M |
|
|
MNTA
1882
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $3.72M | 0.01% |
278,400
-118,700
| -30% | -$1.86M |
|
|
NW.PRC.CL
1883
DELISTED
Natwest Bank Ads Series C
NW.PRC.CL
| $3.72M | 0.01% |
142,754
-48,646
| -25% | -$1.26M |
|
1884
Cathay General Bancorp
CATY
$4.31B
| $3.7M | 0.01% |
+98,271
| New | +$3.73M |
|
1885
Gildan
GIL
$10.6B
| $3.7M | 0.01% |
136,800
+91,200
| +200% | +$2.32M |
|
1886
Veracyte
VCYT
$3.42B
| $3.7M | 0.01% |
402,600
+185,700
| +86% | +$1.52M |
|
1887
Chemed
CHE
$7.02B
| $3.69M | 0.01% |
20,200
-31,700
| -61% | -$5.53M |
|
|
IPAS
1888
DELISTED
Ipass Inc Common Stock
IPAS
| $3.69M | 0.01% |
315,380
+1,981
| +0.6% | +$27.1K |
|
|
INTX
1889
DELISTED
Intersections, Inc.
INTX
| $3.69M | 0.01% |
917,000
+11,000
| +1% | +$42.5K |
|
1890
Energy Recovery
ERII
$399M
| $3.68M | 0.01% |
441,900
+425,500
| +2,595% | +$3.95M |
|
|
VDTH
1891
DELISTED
Videocon d2h Limited
VDTH
| $3.67M | 0.01% |
319,400
+86,800
| +37% | +$848K |
|
|
GIG
1892
DELISTED
GigPeak, Inc.
GIG
| $3.67M | 0.01% |
1,192,200
+225,400
| +23% | +$640K |
|
|
AMNB
1893
DELISTED
American National Bankshares Inc
AMNB
| $3.66M | 0.01% |
98,300
+2,200
| +2% | +$79.2K |
|
1894
Nature's Sunshine
NATR
$269M
| $3.66M | 0.01% |
366,000
+5,900
| +2% | +$68.7K |
|
1895
Natera
NTRA
$44.8B
| $3.65M | 0.01% |
411,400
+90,600
| +28% | +$862K |
|
|
ELGX
1896
DELISTED
Endologix Inc
ELGX
| $3.65M | 0.01% |
50,389
+15,937
| +46% | +$1.05M |
|
|
AVX
1897
DELISTED
AVX Corporation
AVX
| $3.64M | 0.01% |
222,400
-195,400
| -47% | -$3.12M |
|
|
NPTN
1898
DELISTED
NEOPHOTONICS CORP
NPTN
| $3.63M | 0.01% |
402,300
-184,300
| -31% | -$1.92M |
|
1899
StoneX
SNEX
$8.05B
| $3.62M | 0.01% |
482,441
+146,812
| +44% | +$1.09M |
|
|
CBK
1900
DELISTED
Christopher & Banks Corporation
CBK
| $3.62M | 0.01% |
2,442,300
+139,100
| +6% | +$203K |
|
Similar funds
Jim Simons's Q1 2017 Portfolio in Review
As of Q1 2017, Jim Simons held 3,652 positions worth $71.6B, up 13% from $63.2B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Jim Simons deployed $5.19B of net new capital in Q1 2017, opening 433 new positions and adding to 1,585 existing holdings. Its largest new stake was Merck: 7,716,460 shares worth $468M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Walt Disney, an estimated $247M trimmed.
- Jim Simons's largest Q1 2017 buy was Merck: 7,716,460 shares worth $468M.
- Jim Simons added most to Johnson & Johnson in Q1 2017, an estimated $440M increase.
- Jim Simons's biggest Q1 2017 reduction was Walt Disney, cutting an estimated $247M.
- Jim Simons fully exited Linear Technology Corp in Q1 2017, selling an estimated $482M.
- Jim Simons's ten largest holdings make up 7.9% of its $71.6B portfolio in Q1 2017.
- Jim Simons opened 433 new positions and closed 462 in Q1 2017.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $71.6B.
Based on Renaissance Technologies's 13F filing for Q1 2017, filed 12 May 2017.